Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin receptor subtype 1A, commonly referred to as the 5-HT1A receptor, is a major inhibitory G protein-coupled receptor (GPCR) that binds serotonin (5-hydroxytryptamine, 5-HT), a key neurotransmitter in the central nervous system. Upon activation, it inhibits adenylyl cyclase, opens potassium channels, and inhibits calcium channels, leading to neuronal hyperpolarization and reduced excitability. It functions as both an autoreceptor on serotonergic neurons and as a heteroreceptor on other neurons. Dysfunction or altered activity of this receptor is implicated in psychiatric disorders such as depression and anxiety.
Agonism, antagonism, or partial agonism at the 5-HT1A receptor can modulate serotonergic neurotransmission.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin Receptor Subtype 1A (5-HT1A).